Encorafenib, Cetuximab, and mFOLFOX6 in <i>BRAF</i> -Mutated Colorectal Cancer
Article Details
Journal Info
New England Journal of Medicine
Massachusetts Medical Society
Authors (20)
Elena Elez
Vall d’Hebron Hospital Campus, Barcelona
Takayuki Yoshino
National Cancer Center Hospital East, Kashiwa, Japan
Lin Shen
Sara Lonardi
Eric Van Cutsem
University Hospitals Gasthuisberg, Leuven, Belgium
Cathy Eng
Vanderbilt-Ingram Cancer Center, Nashville
Tae Won Kim
Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
Harpreet Singh Wasan
Hammersmith Hospital, Division of Cancer, Imperial College London, London
Jayesh Desai
Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
Fortunato Ciardiello
Rona Yaeger
Timothy S. Maughan
University of Liverpool, Liverpool, United Kingdom
Van K. Morris
University of Texas M.D. Anderson Cancer Center, Houston
Christina Wu
Mayo Clinic, Phoenix, AZ
Tiziana Usari
Pfizer, Milan
Robert Laliberte
Pfizer, Cambridge, MA
Samuel S. Dychter
Pfizer, La Jolla, CA
Xiaosong Zhang
Josep Tabernero
Vall d’Hebron Hospital Campus, Barcelona
Scott Kopetz
University of Texas M.D. Anderson Cancer Center, Houston